Sethuraman Panchanathan, director of the National Science Foundation, will resign from the position 16 months before the scheduled end of his six-year term.
In an email sent to directors and deputy directors of NCI-designated cancer centers, Krzysztof Ptak, director of the NCI Office of Cancer Centers, provided a comparison between the newly issued Cancer Center Support Grant Notice of Funding Opportunity with the previous version of the document.
John Burklow, a near-40-year veteran of NIH, will work his last day as chief of staff on April 25.
On April 15, President Trump signed a wide-ranging executive order that aims to lower drug prices, boost transparency into fees charged by middlemen, and limit Medicare payments for outpatient services provided by hospitals.
Harvard University lawyers rejected the Trump administration’s demand to change the school’s leadership, student disciplinary policies, admissions and hiring, and end diversity, equity, and inclusion practices.
The latest notice of a funding opportunity for the Cancer Center Support Grants released by NCI no longer requires submission of a Plan to Enhance Diversity.
A federal judge ruled that the FDA lacks the statutory authority to regulate laboratory developed tests, finding squarely in favor of plaintiffs in the consolidated lawsuits brought by American Clinical Laboratories Association, Association for Molecular Pathology, and others. ASCP submitted an amicus brief supporting the plaintiffs.
